Livzon Pharmaceutical Group Inc. (1513) has released a circular dated 11 November 2025, together with a notice and proxy form for its 2025 First Extraordinary General Meeting. According to the announcement, both English and Chinese versions of these documents are accessible on the company’s official website (www.livzon.com.cn) and the website of the Hong Kong Stock Exchange (www.hkexnews.hk).

Holders who encounter difficulties obtaining the electronic versions of the documents and wish to receive printed copies are advised to complete and return the enclosed request form to the Hong Kong branch share registrar, Tricor Investor Services Limited. Alternatively, a request can be submitted by email to 1513-ecom@vistra.com. The company will promptly provide the requested materials free of charge.

Non-registered shareholders who prefer receiving future corporate communications by electronic means should coordinate with their respective intermediaries (banks, brokers, custodians, or nominees) and furnish a valid email address. Should the company not receive a functional email address from these intermediaries, it will continue sending printed notification letters regarding the availability of corporate communications on relevant websites.